Last updated at 08 Mar 2024 12:00 PM
Director
DIN: 07078808
Harminder Kaur Bawa is currently associated with 2 companies in various capacities such as Designated Partner and Individual Promoter. They serve as a Director at MILLENNIUM PHYSICIANS LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07078808.Harminder Kaur Bawa has previously been associated with 1 company in roles such as Director.Harminder Kaur Bawa is currently involved in 2 different roles. Their most recent position is with MILLENNIUM ONCOLOGY INDIA PRIVATE LIMITED as a Individual Promoter. The first company Harminder Kaur Bawa was appointed to was MILLENNIUM PHYSICIANS LLP. Harminder Kaur Bawa is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Harminder Kaur Bawa is currently associated with 2 companies in various capacities such as Designated Partner and Individual Promoter. They serve as a Director at MILLENNIUM PHYSICIANS LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07078808.Harminder Kaur Bawa has previously been associated with 1 company in roles such as Director.Harminder Kaur Bawa is currently involved in 2 different roles. Their most recent position is with MILLENNIUM ONCOLOGY INDIA PRIVATE LIMITED as a Individual Promoter. The first company Harminder Kaur Bawa was appointed to was MILLENNIUM PHYSICIANS LLP. Harminder Kaur Bawa is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Female
United States
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (1)
Past Companies (1)
2y 2m 1y 1m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| MILLENNIUM ONCOLOGY INDIA PRIVATE LIMITED | Individual Promoter | 29-Nov-2018 |